David Hinkle
Vermögen: 145 $ am 31.05.2026
Vermögen: 145 $ am 31.05.2026
David A. Hinkle currently works at Boundless Bio, Inc., as CFO, Treasurer & Chief Accounting Officer from 2024.
Mr. Hinkle also formerly worked at Receptos LLC, as CAO, Finance Director & Controller, REMEC, Inc., as Vice President & Controller, and Crinetics Pharmaceuticals, Inc., as Vice President-Finance & Controller from 2018 to 2021.
Mr. Hinkle received his undergraduate degree from California State University-Northridge.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 23.01.2026 | 100 ( 0% ) | 145 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BOUNDLESS BIO, INC. | Finanzdirektor/CFO | 11.10.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01.05.2021 |
| RECEPTOS INC | Finanzdirektor/CFO | 01.12.2014 |
REMEC, Inc.
REMEC, Inc. Telecommunications EquipmentElectronic Technology Designs and makes microwave multi-function modules for microwave transmission systems | Comptroller/Controller/Auditor | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
REMEC, Inc.
REMEC, Inc. Telecommunications EquipmentElectronic Technology Designs and makes microwave multi-function modules for microwave transmission systems | Electronic Technology |
Receptos LLC
Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
California State University-Northridge
California State University-Northridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Boundless Bio, Inc.
Boundless Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that develops cancer therapeutics | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen